Vaxcyte, Inc. (PCVX)
NASDAQ · Healthcare
Vaxcyte, Inc. Operating Income 2020–2025
Vaxcyte, Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Vaxcyte, Inc. operating income for the quarter ending March 31, 2026 was -345.9 M, a 91.30% increase year-over-year.
- Vaxcyte, Inc. operating income for the twelve months ending March 31, 2026 was -1.1 B.
- Vaxcyte, Inc. annual operating income for 2025 was -923.7 M, a 62.18% increase from 2024.
- Vaxcyte, Inc. annual operating income for 2024 was -569.5 M, a 46.69% increase from 2023.
- Vaxcyte, Inc. annual operating income for 2023 was -388.3 M, a 87.27% increase from 2022.
- Vaxcyte, Inc. annual operating income for 2022 was -207.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Vaxcyte, Inc. Operating Income — FAQ
Vaxcyte, Inc. (PCVX) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Vaxcyte, Inc.'s operating income?
Vaxcyte, Inc. (PCVX) reported operating income of -$924M for fiscal 2025.
Where can I see PCVX's operating income history?
The chart and table above show Vaxcyte, Inc.'s operating income by year and by quarter, including the growth rate.